ID   FHUi001-C
SY   MEN1-iPS-20; MEN1_20; 20_3063A1
DR   hPSCreg; FHUi001-C
DR   SKIP; SKIP005760
DR   Wikidata; Q93553585
RX   PubMed=32460232;
CC   From: Fujita Health University; Toyoake; Japan.
CC   Population: Japanese.
CC   Sequence variation: Mutation; HGNC; 7010; MEN1; Simple; p.Arg171_Val173del (c.512_520delGGGATGTCC); Zygosity=Heterozygous (PubMed=32460232).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3225; Multiple endocrine neoplasia type 1
DI   ORDO; Orphanet_652; Multiple endocrine neoplasia type 1
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_YT23 ! FHUi001-A
OI   CVCL_YT24 ! FHUi001-B
SX   Female
AG   Age unspecified
CA   Induced pluripotent stem cell
DT   Created: 12-03-20; Last updated: 29-06-23; Version: 6
RX   PubMed=32460232; DOI=10.1016/j.scr.2020.101846;
RA   Yoshida S., Okura H., Suga H., Nishitomi T., Sakurai A., Arima H.,
RA   Matsuyama A.;
RT   "Generation of three induced pluripotent stem cell (iPSC) lines from a
RT   multiple endocrine neoplasia type 1 (MEN1) patient and three iPSC
RT   lines from an unaffected relative of the patient.";
RL   Stem Cell Res. 46:101846-101846(2020).